The Discounted Cash Flow (DCF) valuation of Lexicon Pharmaceuticals Inc (LXRX) is (11.86) USD. With the latest stock price at 0.67 USD, the upside of Lexicon Pharmaceuticals Inc based on DCF is -1869.7%.
Based on the latest price of 0.67 USD and our DCF valuation, Lexicon Pharmaceuticals Inc (LXRX) is a sell. selling LXRX stocks now will result in a potential gain of 1869.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.8% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (27.56) - (7.84) | (11.86) |
| Upside | -4213.8% - -1270.7% | -1869.7% |